Companies

Fortress Biotech, Inc. (FBIO) SEC filings

CIK 0001429260 · Pharmaceutical Preparations (SIC 2834) · Nasdaq, Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)63.3 M84.5 M75.7 M
Net income (USD)-86.6 M-64.7 M
Diluted EPS (USD/shares)-0.07-8.47-15.97

Latest filings

FiledFormDescriptionPeriod
2026-10-018-K8-K items 8.012026-09-30
2026-10-01442026-10-01
2026-09-01SCHEDULE 13GSCHEDULE 13G
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.02,9.012026-08-13
2026-06-24442026-06-22
2026-06-238-K8-K items 5.072026-06-17
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-1410-Q10-Q2026-03-31
2026-05-148-K8-K items 2.02,9.012026-05-14
2026-04-28DEFA14ADEFA14A
2026-04-28DEF 14ADEF 14A2026-06-17
2026-04-01442026-04-01
2026-03-3110-K10-K2025-12-31
2026-03-318-K8-K items 2.02,9.012026-03-31
2026-03-308-K8-K items 8.01,9.012026-03-30
2026-03-20SCHEDULE 13D/ASCHEDULE 13D/A
2026-03-20442026-03-18
2026-03-20442026-03-18
2026-02-238-K8-K items 1.01,2.03,8.01,9.012026-02-22
2026-01-138-K8-K items 8.01,9.012026-01-13
2026-01-06SCHEDULE 13D/ASCHEDULE 13D/A
2026-01-06442026-01-02
2026-01-05SCHEDULE 13D/ASCHEDULE 13D/A
2026-01-05442026-01-01

Forms on file (last 1,000): 4 251, 8-K 221, 10-Q 45, 3 33, SC 13D/A 27, EFFECT 22, 424B5 22, CORRESP 21. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=FBIO (0.002 USD), /gw/filings/filings?ticker=FBIO&form=8-K, /gw/filings/facts?ticker=FBIO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange